Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals

The number of biotechnology-based pharmaceuticals in the late-stage pipeline has been increasing more than ever. As a result, there is an enhanced demand for more efficient and cost-effective processes. During the last years, the upstream technology for the production of biopharmaceuticals has been...

Full description

Saved in:
Bibliographic Details
Published inJournal of Chromatography A Vol. 1217; no. 16; pp. 2296 - 2305
Main Authors Rosa, P.A.J., Ferreira, I.F., Azevedo, A.M., Aires-Barros, M.R.
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 16.04.2010
Amsterdam; New York: Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The number of biotechnology-based pharmaceuticals in the late-stage pipeline has been increasing more than ever. As a result, there is an enhanced demand for more efficient and cost-effective processes. During the last years, the upstream technology for the production of biopharmaceuticals has been considerably improved. Continuous discoveries in molecular biology and genetics, combined with new advances in media and feed development, have significantly increased the production titres. In order to keep up this gain, it is now essential to design new, as well as to improve the existing downstream processes that remain an unresolved bottleneck. This review evaluates several alternatives to the currently established platforms for the downstream processing biopharmaceuticals, with main focus on aqueous two-phase extraction.
Bibliography:http://dx.doi.org/10.1016/j.chroma.2009.11.034
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9673
1873-3778
DOI:10.1016/j.chroma.2009.11.034